rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Elizabeth Balta

Officer

Company insider

Files Form 4 as: Officer, Jade Biosciences; General Counsel & Corp. Sec., Icosavax.

In numbers

Trades disclosed
9
Buys
0
Sells
2
Bought
$0
Sold
$72K
Companies
2
Companies where not an officer
0
First trade
10 Feb 2022
Last trade
12 Feb 2026
Last filed
13 Feb 2026

Companies traded

Where they are an officer
JBIO Jade BiosciencesOfficer · Biotechnology · last 12 Feb 20260 buys · 0 sells
IcosavaxOfficer · last 15 Feb 20230 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Feb 2026filed 13 Feb 2026JBIO Jade BiosciencesBiotechnologySEC FORM 4 Code A—28,125 at $0.00filing
12 Feb 2026filed 13 Feb 2026JBIO Jade Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—168,750 at $0.00filing
12 Feb 2026filed 13 Feb 2026JBIO Jade Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—168,750 at $0.00filing
12 Feb 2026filed 13 Feb 2026JBIO Jade BiosciencesBiotechnologySEC FORM 4 Code A—28,125 at $0.00filing
15 Feb 2023filed 17 Feb 2023Icosavaxoption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
13 Feb 2023filed 15 Feb 2023IcosavaxSEC FORM 4 Sold$63K5,922 at $10.69filing
10 Nov 2022filed 14 Nov 2022Icosavaxoption or derivativeSEC FORM 4 Code A—88,900 at $0.00filing
8 Sep 2022filed 9 Sep 2022IcosavaxSEC FORM 4 Sold$8,8291,813 at $4.87filing
10 Feb 2022filed 14 Feb 2022IcosavaxSEC FORM 4 Code A—82,992 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Mark EisnerDirector · Director at Jade Biosciences, filing Form 4 there in the last year
Erin LavelleDirector · Director at Jade Biosciences, filing Form 4 there in the last year
Lawrence Otto KleinChief Executive Officer · Director at Jade Biosciences, filing Form 4 there in the last year
Fairmount Funds Management LLCDirector and 10% owner · Director and 10% owner at Jade Biosciences, filing Form 4 there in the last year
Eric DobmeierDirector · Director at Jade Biosciences, filing Form 4 there in the last year